Journals / The Journal of Pediatric Research / 2021 / Cilt: 8 - Sayı: 3

Pediatric COVID-19 Associated Rhabdomyolysis

Pages
363–366
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Timely diagnosis and proper treatment improve the patient’s prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The incidence of rhabdomyolysis secondary to various causes has been reported, especially for viral infections such as influenzas.
📊
Key Findings & Data:It is well established that Coronavirus disease-2019 (COVID-19) can include a large array of symptoms during the disease course, but there have been few reports of COVID-19-related rhabdomyolysis.
💡
Conclusion & Impact:Timely diagnosis and proper treatment improve the patient’s prognosis.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

The incidence of rhabdomyolysis secondary to various causes has been reported, especially for viral infections such as influenzas. It is well established that Coronavirus disease-2019 (COVID-19) can include a large array of symptoms during the disease course, but there have been few reports of COVID-19-related rhabdomyolysis. We report a 10-year-old boy who presented with fever, some dry cough, myalgias, and painful walking. His COVID-19 polymerase chain reaction test performed through the nasopharyngeal swab was positive. His first creatinine kinase level was 8,000 U/L. He was treated with isotonic intravenous fluids because of rhabdomyolysis. Muscle weakness and pain are common symptoms of the 2019 novel COVID, but physicians should be aware of the possibility of rhabdomyolysis, especially when patients complain of local pain and weakness in their muscles. Pediatric clinicians should be aware of this complication related to the novel 2019 coronavirus. Timely diagnosis and proper treatment improve the patient’s prognosis.

🔖

Cite This Article

ARMANPOOR, P., ARMANPOOR, P. (2021). Pediatric COVID-19 Associated Rhabdomyolysis. The Journal of Pediatric Research, Cilt: 8 - Sayı: 3, 363–366. https://ajindex.com/articles/362698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Eng J Med 2020; 382:1708-20
  2. Gefen AM, Palumbo N, Nathan SK, Singer PS, Castellanos-Reyes LJ, Sethna CB. Pediatric COVID-19-associated rhabdomyolysis: a case report. Pediatric Nephrology (Berlin, Germany). 2020 May 23:1
  3. Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol 2011; 26:1781-8
  4. Moniz MS, Mascarenhas MI, Escobar C, et al. Rhabdomyolysis as a manifestation of a metabolic disease: a case report. Rev Bras Ter Intensiva 2017; 29:111-4
  5. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics 2006; 118:2119-25
  6. Fadila MF, Wool KJ. Rhabdomyolysis secondary to influenza a infection: a case report and review of the literature. N Am J Med Sci 2015; 7:122-4
  7. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20:689-96
  8. Gilpin S, Byers M, Byrd A, et al. Rhabdomyolysis as the initial presentation of SARS-CoV-2 in an Adolescent. Pediatrics 2021; 147:e2020019273
  9. Anwar H, Al Lawati A. Adolescent COVID-19-associated fatal rhabdomyolysis. J Prim Care Community Health 2020; 11:2150132720985641
  10. Miller ML. Clinical manifestations and diagnosis of rhabdomyolysis. Up Todate, Version. 2014 and 11. Available from: https://www.uptodate.com/contents/clinical-manifestationsand- diagnosis-of-rhabdomyolysis 11. Disser NP, De Micheli AJ, Schonk MM, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am 2020; 102:1197- 204
  11. Suwanwongse K, Shabarek N. Rhabdomyolysis as a presentation of 2019 novel coronavirus disease. Cureus. 2020 Apr and 12(4)
  12. Inc, Palevsky PM. Prevention and treatment of heme pigmentinduced acute kidney injury (acute renal failure) Uptdate and http://www.uptodate.com/contents/prevention-andtreatment- of-heme-pigment-, c2017. [2015 Nov 16]. Last Accessed Date: 21. 09.2021. Available from: [Internet] Available from:
  13. Geng Y, Ma Q, Du YS, et al. Rhabdomyolysis is associated with in-hospital mortality in patients with COVID-19. Shock. Jan 13. doi: 10.1097/SHK.0000000000001725. Online ahead of print.